News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,006 Results
Type
Article (41303)
Company Profile (269)
Press Release (684424)
Multimedia
Podcasts (82)
Webinars (18)
Section
Business (205960)
Career Advice (2029)
Deals (35646)
Drug Delivery (110)
Drug Development (81457)
Employer Resources (173)
FDA (16429)
Job Trends (15068)
News (347850)
Policy (32763)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2580)
Accelerated approval (31)
Adcomms (24)
Allergies (142)
Alliances (49676)
ALS (170)
Alzheimer's disease (1668)
Antibody-drug conjugate (ADC) (308)
Approvals (16696)
Artificial intelligence (515)
Autoimmune disease (152)
Automation (38)
Bankruptcy (361)
Best Places to Work (11762)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (176)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (638)
Cancer (4796)
Cardiovascular disease (404)
Career advice (1713)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (740)
Cervical cancer (36)
Clinical research (69615)
Collaboration (1699)
Company closure (4)
Compensation (1155)
Complete response letters (54)
COVID-19 (2711)
CRISPR (89)
C-suite (841)
Cystic fibrosis (143)
Data (6213)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (501)
Diagnostics (6732)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (252)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (91217)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (119344)
Executive appointments (975)
FDA (19538)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1469)
Gene editing (194)
Generative AI (43)
Gene therapy (594)
GLP-1 (967)
Government (4661)
Grass and pollen (6)
Guidances (384)
Healthcare (18997)
HIV (58)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (250)
Immuno-oncology (58)
Indications (109)
Infectious disease (2977)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (115)
Intellectual property (248)
Interviews (316)
IPO (16735)
IRA (50)
Job creations (3650)
Job search strategy (1433)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7955)
Liver cancer (91)
Longevity (14)
Lung cancer (645)
Lymphoma (376)
Machine learning (42)
Management (59)
Manufacturing (790)
MASH (162)
Medical device (13890)
Medtech (13943)
Mergers & acquisitions (19980)
Metabolic disorders (1265)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (315)
Neuropsychiatric disorders (88)
Neuroscience (2894)
Neurotech (1)
NextGen: Class of 2026 (6546)
Non-profit (4517)
Now hiring (67)
Obesity (594)
Opinion (257)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (225)
Parkinson's disease (279)
Partnered (33)
Patents (494)
Patient recruitment (488)
Peanut (56)
People (58965)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21701)
Phase 2 (30636)
Phase 3 (22817)
Pipeline (5250)
Policy (281)
Postmarket research (2573)
Preclinical (9207)
Press Release (64)
Prostate cancer (239)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (833)
Real estate (5978)
Recruiting (70)
Regulatory (24495)
Reports (52)
Research institute (2390)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (147)
Series A (239)
Series B (192)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3630)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (999)
Venture capital (89)
Weight loss (380)
Women's health (89)
Worklife (18)
Date
Today (150)
Last 7 days (573)
Last 30 days (2093)
Last 365 days (30128)
2026 (3335)
2025 (30379)
2024 (35395)
2023 (40322)
2022 (51481)
2021 (56042)
2020 (54353)
2019 (46790)
2018 (35216)
2017 (32239)
2016 (31678)
2015 (37822)
2014 (31502)
2013 (26508)
2012 (28734)
2011 (29451)
2010 (27525)
Location
Africa (742)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (39444)
Australia (6435)
California (11326)
Canada (3280)
China (1101)
Colorado (479)
Connecticut (482)
Delaware (335)
Europe (85311)
Florida (1692)
Georgia (358)
Hawaii (3)
Idaho (61)
Illinois (873)
India (65)
Indiana (521)
Iowa (22)
Japan (428)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1388)
Massachusetts (8133)
Michigan (327)
Minnesota (627)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3026)
New Mexico (28)
New York (2975)
North Carolina (1469)
North Dakota (8)
Northern California (5522)
Ohio (333)
Oklahoma (21)
Oregon (41)
Pennsylvania (2276)
Puerto Rico (24)
Rhode Island (47)
South America (1120)
South Carolina (66)
South Dakota (1)
Southern California (4410)
Tennessee (174)
Texas (1746)
United States (40190)
Utah (335)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (933)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
726,006 Results for "arch biopartners inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board
January 19, 2026
·
5 min read
Press Releases
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
February 9, 2026
·
5 min read
Press Releases
Arch Biopartners Closes Non-Brokered Private Placement
November 20, 2025
·
4 min read
Press Releases
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
November 6, 2025
·
5 min read
Press Releases
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
December 16, 2025
·
9 min read
Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
Arch Biopartners Inc. announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilastatin, the Company’s second drug candidate for preventing acute kidney injury (AKI).
June 27, 2024
·
5 min read
Press Releases
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
July 23, 2025
·
6 min read
Press Releases
Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury
August 6, 2025
·
8 min read
Press Releases
Endospan Announces Positive One-Year Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System
February 4, 2026
·
3 min read
Drug Development
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
Arch Biopartners Inc. announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
June 18, 2024
·
5 min read
1 of 72,601
Next
